Catalyst Wire Dossier Catalyst Wire Dossier

Dabigatran Etexilate 150 mg Capsule

dabigatran etexilate · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dabigatran Etexilate 150 mg Capsule, covering 2024-06-06 to 2024-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions [Phase 1]

See pricing